CD276 and ovarian cancer: This, in turn, impairs the efficacy of the therapeutic intervention.52 To assess the induction of this phenomenon known as antigen shift, we examined B7-H3 expression after incubating ovarian cancer cells with 8H8-SDIE (range 0.0003–10 μg/mL) for 24 and 72 hours.